SHANGHAI – LAWFUEL – Asia Business & Law – October 11, 2006 – O’Melveny & Myers LLP represented Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices in China, in its initial public offering of American depositary shares (ADSs) on the New York Stock Exchange. The offering, including ADSs issued upon exercise of the underwriters’ option at closing, consisted of 23 million ADSs at US$13.50 per ADS.
The US$310.5 million offering consisted of 12,643,000 ADSs offered by Mindray and 10,357,000 ADSs offered by selling shareholders. Mindray expects to use the net proceeds from this offering to construct a new headquarters building and expand its manufacturing, assembly and warehouse facilities, including the potential relocation into a new facility in Shenzhen, China, and to fund working capital and for other general corporate purposes. Mindray did not receive any of the proceeds from the sale of the ADSs by any of the selling shareholders. Goldman Sachs (Asia) L.L.C. and UBS AG acted as joint book-running managers. Mindray’s ADSs are listed on the New York Stock Exchange under the symbol “MR”.
The O’Melveny team included partners Kurt Berney and Doug Freeman, counsels Portia Ku and Scott Graziano, associates Tim Fitzpatrick and Weishi Li, and legal consultants Edward Yee and Jiahua Wu. Partners Larry Sussman and Luc Moritz and senior legal consultant Min Huang provided tax advice on the offering.
About Mindray
Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring devices, diagnostic laboratory instruments and ultrasound imaging systems. Mindray is headquartered in Shenzhen, China, and has 29 local sales and services offices in China, as well as representative offices in the Boston, London, Vancouver and Istanbul.
About O’Melveny & Myers LLP
O’Melveny & Myers LLP is a values-driven law firm guided by the principles of excellence, leadership, and citizenship. With the breadth, depth, and foresight to serve clients competing in a global economy, our lawyers devise innovative approaches to resolve problems and achieve business goals. Established in 1885, the firm maintains 13 offices around the world, with more than 1,000 lawyers. O’Melveny & Myers’ capabilities span virtually every area of legal practice, including Antitrust/Competition; Appellate; Class Actions, Mass Torts & Aggregated Litigation; Corporate; Corporate Finance; Electronic Discovery; Entertainment & Media; Global Enforcement & Criminal Defense; Health Care & Life Sciences; Insurance; Intellectual Property & Technology; Labor & Employment; Mergers & Acquisitions; Private Equity; Project Development & Real Estate; Restructuring; Securities Enforcement & Regulatory Counseling; Securities Litigation; Strategic Counseling; Tax; and Trial & Litigation.
